Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exozymes (EXOZ) Change in Receivables (2023 - 2024)

Exozymes (EXOZ) has disclosed Change in Receivables for 2 consecutive years, with $183319.0 as the latest value for Q4 2024.

  • Quarterly Change in Receivables fell 10.95% to $183319.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$145037.0 through Dec 2024, changed N/A year-over-year, with the annual reading at -$219923.0 for FY2025, 51.63% down from the prior year.
  • Change in Receivables for Q4 2024 was $183319.0 at Exozymes, up from -$593208.0 in the prior quarter.
  • The five-year high for Change in Receivables was $229292.0 in Q1 2024, with the low at -$593208.0 in Q3 2024.